RECENT PAST NEWS IN MDR-TB

Joint GLI-GDI Workshop: access to diagnostics, treatment, and care to end TB

Watch our most recent webinar

Fighting tuberculosis with medication, mental health, and social support

Innovative tools take aim at antibiotic-resistant microbes

How COVID is derailing the fight againstHIV, TB, and Malaria

New Trial Shows Effectiveness of BPaL Regimen for Highly Drug-Resistant TB

WHO 2021 Genetic Susceptibility Testing Statement

The Tuberculosis Drug Accelerator at year 10: what have we learned?

WHO GLOBAL TB PROGRAMME NEWSFLASH

WHO releases new global lists of high-burden countries for TB, HIV-associated TB and DR-TB

Low-Dose Amikacin as Alternative Treatment for Multidrug-Resistant Tuberculosis

Shorter treatment regimen found to be effective for treating TB

Tailor-made therapy of multi-resistant tuberculosis

WHO TB Treatment Outcome Definitions

24-month follow-up confirms efficacy of NiX-TB regimen for XDR-TB

MDR-TB trial 6-month regimen appears effective

TB Molecular Assay Updates—WHO

New TB tests and drugs remain out of reach

Rifampicin Susceptibility Testing Update

WHO Updates Definition of DR and XDR-TB